factor viii variant, polynucleotide, expression vector, mammalian cell, methods for producing a fviii variant and for treating a patient suffering from hemophilia, and, pharmaceutical composition

摘要

The present invention is in the field of hemophilia therapy. It relates to a new variant of antihemophilic factor VIII having increased specific activity in comparison to known factor VIII products.